The link between selenium and chemoprevention: A case for selenoproteins

Journal of Nutrition

Volumn 134, Issue 11, 2004, Pages 2899-2902

  Diwadkar Navsariwala, Veda ^a   Diamond, Alan M ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Chemoprevention; Glutathione peroxidase; Selenium; Selenoproteins

Indexed keywords

ADENINE; AMINO ACID; GLUTATHIONE PEROXIDASE; GUANINE; PEPTIDE; SELENIUM; SELENOCYSTEINE; SELENOPROTEIN; URACIL;

ALLELE; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CARCINOGENESIS; CHEMOPROPHYLAXIS; CODON; DIET SUPPLEMENTATION; EXPERIMENTAL MODEL; GENE EXPRESSION PROFILING; GENE INSERTION; GENE LOCUS; GENE LOSS; GENETIC RISK; GENETIC VARIABILITY; GENOME ANALYSIS; HETEROZYGOSITY LOSS; HUMAN; NONHUMAN; PROTEIN FUNCTION; PROTEIN SYNTHESIS; RNA TRANSLATION;

ANIMALIA; INSERTION SEQUENCES; MAMMALIA;

EID: 7944232835     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/134.11.2899     Document Type: Article

References (50)

1. El-Bayoumy, K. (1991) The role of selenium in cancer prevention. In: Cancer Prevention (DeVita, V. T., Hellman, S. & Rosenberg, S. A., eds.), pp. 1-15. J. B. Lippincott, Philadelphia, PA.
2. Yoshizawa, K., Willett, W. C., Morris, S. J., Stampfer, M. J., Spiegelman, D., Rimm, E. B. & Giovannucci, E. (1998) Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J. Natl. Cancer Inst. 90: 1219-1224.
3. Ghadirian, P., Maisonneuve, P., Perret, C., Kennedy, G., Boyle, P., Krewski, D. & Lacroix, A. (2000) A case-control study of toenail selenium and cancer of the breast, colon, and prostate. Cancer Detect. Prev. 24: 305-313.
4. Brooks, J. D., Metter, E. J., Chan, D. W., Sokoll, L. J., Landis, P., Nelson, W. G., Muller, D., Andres, R. & Carter, H. B. (2001) Plasma selenium level before diagnosis and the risk of prostate cancer development. J. Urol. 166: 2034-2038.
5. Fernandez-Banares, F., Cabre, E., Esteve, M., Mingorance, M. D., Abad-Lacruz, A., Lachica, M., Gil, A. & Gassull, M. A. (2002) Serum selenium and risk of large size colorectal adenomas in a geographical area with a low selenium status. Am. J. Gastroenterol. 97: 2103-2108.
6. Knekt, P., Marniemi, J., Teppo, L., Heliovaara, M. & Aromaa, A. (1998) Is low selenium status a risk factor for lung cancer? Am. J. Epidemiol. 148: 975-982.
7. Garland, M., Morris, J. S., Stampfer, M. J., Colditz, G. A., Spate, V. L., Baskett, C. K., Rosner, B., Speizer, F. E., Willett, W. C. & Hunter, D. J. (1995) Prospective study of toenail selenium levels and cancer among women. J. Natl. Cancer Inst. 87: 497-505.
8. Clark, L. C., Combs, G.F.J., Turnbull, B. W., Slate, E. H., Chalker, E. H., Chow, J., Davis, L. S., Glover, R. A., Graham, G. F., Gross, E. G., Krongrad, A., Lesher, J.L.J., Park, H. K., Sanders, B.B.J., Smith, C. L. & Taylor, J. R. (1996) Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. J. Am. Med. Assoc. 276: 1957-1963.
9. Yu, S. Y., Zhu, Y. J. & Li, W. G. (1997) Protective role of selenium against hepatitis B virus and primary liver cancer in Qidong. Biol. Trace Elem. Res. 56: 117-124.
10. Kryukov, G. V., Castellano, S., Novoselov, S. V., Lobanov, A. V., Zehtab, O., Guigo, R. & Gladyshev, V. N. (2003) Characterization of mammalian selenoproteomes. Science (Washington, DC) 300: 1439-1443.
11. Hatfield, D. L. & Gladyshev, V. N. (2002) How selenium has altered our understanding of the genetic code. Mol. Cell Biol. 22: 3565-3576.
12. Zinoni, F., Birkmann, A., Leinfelder, W. & Bock, A. (1987) Cotranslational insertion of selenocysteine into formate dehydrogenase from Escherichia coli directed by a UGA codon. Proc. Natl. Acad. Sci. U.S.A. 84: 3156-3160.
13. Berry, M. J., Banu, L., Harney, J. W. & Larsen, P. R. (1993) Functional characterization of the eukaryotic SECIS elements which direct selenocysteine insertion at UGA codons. EMBO J. 12: 3315-3322.
14. Brigelius-Flohe, R. (1999) Tissue-specific functions of individual glutathione peroxidases. Free Radic. Biol. Med. 27: 951-965.
15. Ho, Y. S., Magnenat, J. L., Bronson, R. T., Cao, J., Gargano, M., Sugawara, M. & Funk, C. D. (1997) Mice deficient in cellular glutathione peroxidase develop normally and show no increased sensitivity to hyperoxia. J. Biol. Chem. 272: 16644-16651.
16. Ho, Y. S., Gargano, M., Cao, J., Bronson, R. T., Heimler, I. & Hutz, R. J. (1998) Reduced fertility in female mice lacking copper-zinc Superoxide dismutase. J. Biol. Chem. 273: 7765-7769.
17. Esworthy, R. S., Binder, S. W., Doroshow, J. H. & Chu, F. F. (2003) Microflora trigger colitis in mice deficient in selenium-dependent glutathione peroxidase and induce Gpx2 gene expression. Biol. Chem. 384: 597-607.
18. Moscow, J. A., Schmidt, L., Ingram, D. T., Gnarra, J., Johnson, B. & Cowan, K. H. (1994) Loss of heterozygosity of the human cytosolic glutathione peroxidase I gene in lung cancer. Carcinogenesis 15: 2769-2773.
19. Ratnasinghe, D., Tangrea, J. A., Andersen, M. R., Barrett, M. J., Virtamo, J., Taylor, P. R. & Albanes, D. (2000) Glutathione peroxidase codon 198 polymorphism variant increases lung cancer risk. Cancer Res. 60: 6381-6383.
20. Ichimura, Y., Habuchi, T., Tsuchiya, N., Wang, L., Oyama, C., Sato, K., Nishiyama, H., Ogawa, O. & Kato, T. (2004) Increased risk of bladder cancer associated with a glutathione peroxidase 1 codon 198 variant. J. Urol. 172: 728-732.
21. Hu, Y. J. & Diamond, A. M. (2003) Role of glutathione peroxidase 1 in breast cancer: loss of heterozygosity and allelic differences in the response to selenium. Cancer Res. 63: 3347-3351.
22. Forsberg, L., de Faire, U., Marklund, S. L., Andersson, P. M., Stegmayr, B. & Morgenstern, R. (2000) Phenotype determination of a common Pro-Leu polymorphism in human glutathione peroxidase 1. Blood Cells Mol. Dis. 26: 423-426.
23. Shen, Q., Townes, P. L., Padden, C. & Newburger, P. E. (1994) An in-frame trinucleotide repeat in the coding region of the human cellular glutathione peroxidase (GPX1) gene: in vivo polymorphism and in vitro instability. Genomics 23: 292-294.
24. Knight, J. A., Onay, U. V., Wells, S., Li, H., Shi, E. J., Andrulis, I. L. & Ozcelik, H. (2004) Genetic variants of GPX1 and SOD2 and breast cancer risk at the Ontario site of the Breast Cancer Family Registry. Cancer Epidemiol. Biomark. Prev. 13: 146-149.
25. Kote-Jarai, Z., Durocher, F., Edwards, S. M., Hamoudi, R., Jackson, R. A., Ardern-Jones, A., Murkin, A., Dearnaley, D. P., Kirby, R., Houlston, R., Easton, D. F. & Eeles, R. (2002) Association between the GCG polymorphism of the selenium dependent GPX1 gene and the risk of young onset prostate cancer. Prostate Cancer Prostatic Dis. 5: 189-192.
26. Hardie, L. J., Briggs, J. A., Davidson, L. A., Allan, J. M., King, R. F., Williams, G. I. & Wild, C. P. (2000) The effect of hOGG1 and glutathione peroxidase I genotypes and 3p chromosomal loss on 8-hydroxydeoxyguanosine levels in lung cancer. Carcinogenesis 21: 167-172.
27. Hu, Y. J., Dolan, M. E., Bae, R., Yee, Y., Roy, M., Glickman, R., Kiremidjian-Schumacher, L. & Diamond, A. M. (2004) Allelic loss at the GPx-1 locus and the risk for cancer of the head and neck. Biol. Trace Elements Res. (in press).
28. Villette, S., Kyle, J. A., Brown, K. M., Pickard, K., Milne, J. S., Nicol, F., Arthur, J. R. & Hesketh, J. E. (2002) A novel single nucleotide polymorphism in the 3′ untranslated region of human glutathione peroxidase 4 influences lipoxygenase metabolism. Blood Cells Mol. Dis. 29: 174-178.
29. Gladyshev, V. N., Jeang, K., Wootton, J. C. & Hatfield, D. L. (1998) A new human selenium-containing protein. J. Biol. Chem. 273: 8910-8915.
30. Korotkov, K. V., Kumaraswamy, E., Zhou, Y., Hatfield, D. L. & Gladyshev, V. N. (2001) Association between the 15-kDa selenoprotein and UDP-glucose: glycoprotein glucosyltransferase in the endoplasmic reticulum of mammalian cells. J. Biol. Chem. 276: 15330-15336.
31. Wu, H. J., Lin, C., Zha, Y. Y., Yang, J. G., Zhang, M. C., Zhang, X. Y., Liang, X., Fu, M. & Wu, M. (2003) Redox reactions of Sep15 and its relationship with tumor development. Ai Zheng. 22: 119-122.
32. Kumaraswamy, E., Korotkov, K. V., Diamond, A. M., Gladyshev, V. N. & Hatfield, D. L. (2002) Genetic and functional analysis of mammalian Sep15 selenoprotein. Methods Enzymol. 347: 187-197.
33. Hu, Y. J., Korotkov, K. V., Mehta, R., Hatfield, D. L., Rotimi, C. N., Luke, A., Prewitt, T. E., Cooper, R. S., Stock, W., Vokes, E. E., Dolan, M. E., Gladyshev, V. N. & Diamond, A. M. (2001) Distribution and functional consequences of nucleotide polymorphisms in the 3′-untranslated region of the human Sep15 gene. Cancer Res. 61: 2307-2310.
34. Apostolou, S., Klein, J. O., Mitsuuchi, Y., Shetler, J. N., Poulikakos, P. I., Jhanwar, S. C., Kruger, W. D., Testa, J. R., Wu, H. J., Lin, C., Zna, Y. Y., Yang, J. G., Zhang, M. C., Zhang, X. Y., Liang, X., Fu, M. & Wu, M. (2004) Growth inhibition and induction of apoptosis in mesothelioma cells by selenium and dependence on selenoprotein SEP15 genotype. Oncogene 23: 5032-5040.
35. Nasr, M. A., Hu, Y. J. & Diamond, A. M. (2004) Allelic loss at the Sep15 locus in breast cancer. Cancer Then 1: 307-312.
36. Mustacich, D. & Powis, G. (2000) Thioredoxin reductase. Biochem. J. 346: 1-8.
37. Rundlof, A. & Arner, E.S.J. (2004) Regulation of the mammalian selenoprotein thioredoxin reductase 1 in relation to cellular phenotype, growth, and signaling events. Antioxid. Redox Signal. 6: 41-52.
38. Gladyshev, V. N., Factor, V. M., Housseau, F. & Hatfield, D. L. (1998) Contrasting patterns of regulation of the antioxidant selenoproteins thioredoxin reductase and glutathione peroxidase, in cancer cells. Biochem. Biophys. Res. Commun. 251: 488-49.
39. Lincoln, D. T., Ali Emadi, E. M., Tonissen, K. F. & Clarke, F. M. (2003) The thioredoxin-thioredoxin reductase system: over-expression in human cancer. Anticancer Res. 23: 2425-2433.
40. Kim, H. J., Chae, H. Z., Kim, Y. J., Hwangs, T. S., Park, E. M. & Park, Y. M. (2003) Preferential elevation of Prx I and Trx expression in lung cancer cells following hypoxia and in human lung cancer tissues. Cell Biol. Toxicol. 19: 285-298.
41. Pearson, G. D. & Merrill, G. F. (1997) Deletion of the Saccharomyces cerevisiae TRR1 gene encoding thioredoxin reductase inhibits p53-dependent reporter gene expression. J. Biol. Chem. 273: 5431-5434.
42. Ueno, M., Masutani, H., Arai, R. J., Yamauchi, A., Hirota, K., Sakai, T., Inamoto, T., Yamaoka, Y., Yodoi, J. & Nikaido, T. (1999) Thioredoxin-dependent redox regulation of p53-mediated p21 activation. J. Biol. Chem. 274: 35809-35815.
43. Moos, P. J., Edes, K., Cassidy, P., Massuda, E. & Fitzpatrick, F. A. (2003) Electrophilic prostaglandins and lipid aldehydes repress redox-senstive transcription factors p53 and hypoxia-inducible factor by impairing the selenoprotein thioredoxin reductase. J. Biol. Chem. 278: 745-750.
44. Turunen, N., Karihtala, P., Mantyniemi, A., Sormunen, R., Holmgren, A., Kinnula, V. L. & Soini, Y. (2004) Thioredoxin is associated with proliferation, p53 expression and negative estrogen and progesterone receptor status in breast carcinoma. APMIS 112: 123-132.
45. Burk, R. F., Hill, K. E. & Motley, A. K. (2003) Selenoprotein metabolism and function: evidence for more than one function for selenoprotein P. J. Nutr. 133: 1517S-1520S.
46. Schomburg, L., Schweizer, U., Holtmann, B., Flohe, L., Sendtner, M. & Kohrle, J. (2003) Gene disruption discloses role of selenoprotein P in selenium delivery to target tissues. Biochem. J. 370: 397-402.
47. Hill, K. E., Zhou, J., McMahan, W. J., Motley, A. K., Atkins, J. F., Gesteland, R. F. & Burk, R. F. (2003) Deletion of selenoprotein P alters distribution of selenium in mouse. J. Biol. Chem. 278: 13640-13646.
48. Mork, H., Al-Taie, O. H., Bahr, K., Zierer, A., Beck, C., Scheurlen, M., Jakob, F. & Kohrle, J. (2000) Inverse mRNA expression of the selenocysteine-containing proteins GI-GPx and SeP in colorectal adenomas compared with adjacent normal mucosa. Nutr. Cancer 37: 108-116.
49. Al-Taie, O. H., Uceyler, N., Eußner, U., Jakob, F., Mork, H., Scheurlen, M., Brigelius-Flohe, R., Schottker, K., Able, J., Thalheimer, A., Katzenberger, T., Illert, B., Melcher, R. & Kohrle, J. (2004) Expression profiling and genetic alterations of the selenoproteins GI-GPx and SePP in colorectal carcinogenesis. Nutr. Cancer 48: 6-14.
50. Clement, I. (1998) Lessons from basic research in selenium and cancer prevention. J. Nutr. 128: 1845-1854.